Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Series A Deal Volume And Money Up In H1

This article was originally published in Start Up

Executive Summary

Biopharma, medtech and diagnostics start-ups raised a whopping 51% more Series A money in the first half of 2015 than during the same period last year, and the number of deals was way up too.

Advertisement

Related Content

GSK/Avalon Incubator Launches New Firms For Cardiac, Cancer, Lysosomal Storage Disorders
The A-List: The Trend-Shaping Series A Financings Of 2014
Series A Rounds H1 2014: Fewer Deals, Comparable Money

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register